Polygenic hazard scores in preclinical Alzheimer disease-Reference-Cited by-同舟云学术

Polygenic hazard scores in preclinical Alzheimer disease

Published:2017-09 Issue:3 Volume:82 Page:484-488
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Tan Chin Hong¹,Hyman Bradley T.²,Tan Jacinth J. X.³,Hess Christopher P.¹,Dillon William P.¹,Schellenberg Gerard D.⁴,Besser Lilah M.⁵,Kukull Walter A.⁵,Kauppi Karolina⁶,McEvoy Linda K.⁶,Andreassen Ole A.⁷,Dale Anders M.⁶⁸⁹,Fan Chun Chieh⁹,Desikan Rahul S.¹¹⁰

Affiliation:

1. Neuroradiology Section, Department of Radiology and Biomedical Imaging; University of California, San Francisco; San Francisco CA

2. Department of Neurology; Massachusetts General Hospital; Boston MA

3. Center for Health and Community; University of California, San Francisco; San Francisco CA

4. Department of Pathology and Laboratory Medicine; University of Pennsylvania Perelman School of Medicine; Philadelphia PA

5. National Alzheimer's Coordinating Center, Department of Epidemiology; University of Washington; Seattle WA

6. Department of Radiology; University of California, San Diego; La Jolla CA

7. NORMENT Institute of Clinical Medicine; University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital; Oslo Norway

8. Department of Neurosciences; University of California, San Diego; La Jolla CA

9. Department of Cognitive Science; University of California, San Diego; La Jolla CA

10. Department of Neurology; University of California, San Francisco; San Francisco CA

Funder

Radiological Society of North America

American Society of Neuroradiology

Research Council of Norway

European Union Joint Program-Neurodegenerative Disease Research

South East Norway Health Authority

Norwegian Health Association

Kristian Gerhard Jebsen Foundation

National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference17 articles.

1. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria;Dubois;Alzheimers Dement,2016

2. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;Sperling;Alzheimers Dement,2011

3. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy;Bu;Nat Rev Neurosci,2009

4. Age-dependent effects of APOE ɛ4 in preclinical Alzheimer's disease;Bonham;Ann Clin Transl Neurol,2016

5. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment;Caselli;Arch Neurol,2007

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygenic hazard score predicts synaptic and axonal degeneration and cognitive decline in Alzheimer's disease continuum;Archives of Gerontology and Geriatrics;2024-12

2. Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease;International Journal of Molecular Sciences;2024-01-19

3. Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

4. Alzheimer’s disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults;Brain Communications;2024

5. Emerging Microglial Therapies and Targets in Clinical Trial;Advances in Neurobiology;2024